Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
compound embryonic bovine liver extract
- Development stage
- Unknown
- Lead developer
- Beijing No.1 Biochemical Pharmaceutical
- Modality
- Recombinant Proteins and Enzymes, Peptides, Small Molecules
- Administration
- Oral
01
Overview
Compound embryonic bovine liver extract is a hepatoprotective pharmaceutical product primarily used in China for the treatment of chronic liver diseases, including nonalcoholic fatty liver disease (NAFLD), chronic hepatitis, and early-stage liver cirrhosis. It is a combination formulation typically containing embryonic bovine liver extract, inositol, and vitamin B12 (cyanocobalamin). The embryonic bovine liver extract component is rich in hepatocyte growth factor (HGF), insulin-like growth factor (IGF), and various amino acids and peptides that stimulate hepatocyte regeneration and repair. Inositol and vitamin B12 act as lipotropic agents, promoting the metabolism of fats and reducing hepatic steatosis. The drug is marketed under the brand name Anfate and is manufactured by companies such as Zhejiang DND Pharmaceutical.
- Brand names
- AnfateAn Fa Te安珐特
- Other names
- Compound Embryonic Bovine Liver Extract TabletsFufang Tainiugan Tiquwu Pian复方胎牛肝提取物片
02
Targets
IGF-1R (Insulin-like growth factor 1 receptor)MET (Mesenchymal-epithelial transition factor receptor)
Beyond the preview
Go deeper on compound embryonic bovine liver extract.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on compound embryonic bovine liver extract.